A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model D Bugybayeva, Z Kydyrbayev, N Zinina, N Assanzhanova, ... Infectious Diseases of Poverty 10 (01), 56-65, 2021 | 17 | 2021 |
A split influenza vaccine formulated with a combination adjuvant composed of alpha-d-glucan nanoparticles and a STING agonist elicits cross-protective immunity … V Patil, JF Hernandez-Franco, G Yadagiri, D Bugybayeva, S Dolatyabi, ... Journal of Nanobiotechnology 20 (1), 477, 2022 | 12 | 2022 |
An orf-virus (ORFV)-based vector expressing a consensus H1 hemagglutinin provides protection against diverse swine influenza viruses GM do Nascimento, D Bugybayeva, V Patil, J Schrock, G Yadagiri, ... Viruses 15 (4), 994, 2023 | 10 | 2023 |
Development of human vectored brucellosis vaccine formulation: assessment of safety and protectiveness of influenza viral vectors expressing Brucella immunodominant proteins in … D Bugybayeva, S Ryskeldinova, N Zinina, M Sarmykova, ... BioMed Research International 2020 (1), 1438928, 2020 | 8 | 2020 |
Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies S Ryskeldinova, N Zinina, Z Kydyrbayev, B Yespembetov, Y Kozhamkulov, ... Frontiers in cellular and infection microbiology 11, 669196, 2021 | 5 | 2021 |
Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with … JF Hernandez-Franco, G Yadagiri, V Patil, D Bugybayeva, S Dolatyabi, ... Vaccines 11 (11), 1699, 2023 | 2 | 2023 |
Correction: A split influenza vaccine formulated with a combination adjuvant composed of alpha-D-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs V Patil, JF Hernandez-Franco, G Yadagiri, D Bugybayeva, S Dolatyabi, ... Journal of Nanobiotechnology 20, 2022 | 2 | 2022 |
Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs V Patil, JF Hernandez-Franco, G Yadagiri, D Bugybayeva, S Dolatyabi, ... Vaccines 11 (11), 1707, 2023 | 1 | 2023 |
Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose–Chitosan Nanoparticle-Based Intranasal Vaccine in Swine D Bugybayeva, E Dumkliang, V Patil, G Yadagiri, R Suresh, M Singh, ... Vaccines 12 (6), 647, 2024 | | 2024 |
Characterization of a novel functional porcine CD3+ CD4lowCD8α+ CD8β+ T-helper/memory lymphocyte subset in the respiratory tract lymphoid tissues of swine influenza A virus … V Patil, G Yadagiri, D Bugybayeva, J Schrock, R Suresh, ... Veterinary Immunology and Immunopathology, 110785, 2024 | | 2024 |
Evaluation of surface coated versus entrapped mannose-chitosan nanoparticle based intranasal inactivated vaccine against influenza A virus in swine D Bugybayeva The Ohio State University, 2023 | | 2023 |
Plant derived Nano-11 particle adsorbed with stimulator of interferon genes adjuvant and split influenza virus antigens elicits the cross-protective immunity in pigs RJ Gourapura, V Patil, JF Hernandez-Franco, G Yadaigiri, D Bugybayeva, ... The Journal of Immunology 208 (1_Supplement), 124.12-124.12, 2022 | | 2022 |
O5-1 Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies S Ryskeldinova, N Zinina, Z Kydyrbayev, B Yespembetov, Y Kozhamkulov, ... Brucellosis 2022 International Research Conference, 2022 | | 2022 |
A new candidate vaccine for human brucellosis based on influenza viral vectors: development of immunization schedule in guinea pig model D Bugybayeva, Z Kydyrbayev, N Zinina, N Assanzhanova, ... | | 2020 |
Safety of a new intranasal vaccine against equine influenza: a study of the stability of the ts ca phenotype of the reassortant strain in a natural host N Assanzhanova, S Ryskeldinova, E Kozhamkulov, D Bugybayeva, ... Adv. Anim. Vet. Sci 8 (12), 1356-1361, 2020 | | 2020 |
TOWARDS NEW HUMAN BRUCELLOSIS VACCINE: SELECTING IMMUNIZATION MODALITY DA Bugybayeva, SZ Ryskeldinova, ZK Kydyrbayev, YM Kozhamkulov, ... Медицина (Алматы), 35-40, 2019 | | 2019 |